Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jerusalem

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 7, 2020
Randomized controlled trial of a group intervention combining self-hypnosis and self-care: secondary results on self-esteem, emotional distress and regulation, and mindfulness in post-treatment cancer patientsC Grégoire, M-E Faymonville, A Vanhaudenhuyse, et al.
Revue Medicale De Liege|June 10, 2015
[Management of febrile neutropenia in cancer patients]P Freres, E Gonne, J Collignon, et al.
Revue Medicale De Liege|August 11, 2011
[Molecular and genetic aspects of triple negative breast cancer and therapeutic implications]J Collignon, I Struman, S Tabruyn, et al.
Revue Medicale De Liege|July 29, 2014
[Aging and cancer: coincidence or etiologic relationship?]A Duray, S Demoulin, J Petermans, et al.
Revue Medicale De Liege|September 26, 2009
[Angiosarcoma in chronic lymphoedema: a case of Stewart-Treves syndrome]E Gonne, J Collignon, W Kurth, et al.
Haematologica|June 28, 2000
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphomaG Jerusalem, Y Beguin, M F Fassotte, et al.
Haematologica|March 20, 2001
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's diseaseG Jerusalem, Y Beguin, M F Fassotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)G Jerusalem, Y Beguin, F Najjar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's diseaseG Jerusalem, Y Beguin, M F Fassotte, et al.
Nuclear Medicine Communications|February 9, 1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphomaG Jerusalem, V Warland, F Najjar, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 7, 2020
Randomized controlled trial of a group intervention combining self-hypnosis and self-care: secondary results on self-esteem, emotional distress and regulation, and mindfulness in post-treatment cancer patientsC Grégoire, M-E Faymonville, A Vanhaudenhuyse, et al.
Revue Medicale De Liege|June 10, 2015
[Management of febrile neutropenia in cancer patients]P Freres, E Gonne, J Collignon, et al.
Revue Medicale De Liege|August 11, 2011
[Molecular and genetic aspects of triple negative breast cancer and therapeutic implications]J Collignon, I Struman, S Tabruyn, et al.
Revue Medicale De Liege|July 29, 2014
[Aging and cancer: coincidence or etiologic relationship?]A Duray, S Demoulin, J Petermans, et al.
Revue Medicale De Liege|September 26, 2009
[Angiosarcoma in chronic lymphoedema: a case of Stewart-Treves syndrome]E Gonne, J Collignon, W Kurth, et al.
Haematologica|June 28, 2000
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphomaG Jerusalem, Y Beguin, M F Fassotte, et al.
Haematologica|March 20, 2001
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's diseaseG Jerusalem, Y Beguin, M F Fassotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)G Jerusalem, Y Beguin, F Najjar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's diseaseG Jerusalem, Y Beguin, M F Fassotte, et al.
Nuclear Medicine Communications|February 9, 1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphomaG Jerusalem, V Warland, F Najjar, et al.
Pageof 9